These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 18729192)
1. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Palayoor ST; Mitchell JB; Cerna D; Degraff W; John-Aryankalayil M; Coleman CN Int J Cancer; 2008 Nov; 123(10):2430-7. PubMed ID: 18729192 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661 [TBL] [Abstract][Full Text] [Related]
3. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor. Lee K; Kim HM Arch Pharm Res; 2011 Oct; 34(10):1583-5. PubMed ID: 22076756 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012 [TBL] [Abstract][Full Text] [Related]
5. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects. Schwartz DL; Powis G; Thitai-Kumar A; He Y; Bankson J; Williams R; Lemos R; Oh J; Volgin A; Soghomonyan S; Nishii R; Alauddin M; Mukhopadhay U; Peng Z; Bornmann W; Gelovani J Mol Cancer Ther; 2009 Apr; 8(4):947-58. PubMed ID: 19372568 [TBL] [Abstract][Full Text] [Related]
6. Effect of small interfering RNA targeting hypoxia-inducible factor-1α on radiosensitivity of PC3 cell line. Huang Y; Yu J; Yan C; Hou J; Pu J; Zhang G; Fu Z; Wang X Urology; 2012 Mar; 79(3):744.e17-24. PubMed ID: 22196409 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. Zhao T; Ren H; Jia L; Chen J; Xin W; Yan F; Li J; Wang X; Gao S; Qian D; Huang C; Hao J Oncotarget; 2015 Feb; 6(4):2250-62. PubMed ID: 25544770 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Welsh S; Williams R; Kirkpatrick L; Paine-Murrieta G; Powis G Mol Cancer Ther; 2004 Mar; 3(3):233-44. PubMed ID: 15026543 [TBL] [Abstract][Full Text] [Related]
9. Atorvastatin enhances radiosensitivity in hypoxia-induced prostate cancer cells related with HIF-1α inhibition. Chen B; Zhang M; Xing D; Feng Y Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28760843 [TBL] [Abstract][Full Text] [Related]
10. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice. Pan X; Lv Y Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. Shrestha P; Davis DA; Veeranna RP; Carey RF; Viollet C; Yarchoan R PLoS Pathog; 2017 Sep; 13(9):e1006628. PubMed ID: 28922425 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIF-1α Affects Autophagy Mediated Glycosylation in Oral Squamous Cell Carcinoma Cells. Li YN; Hu JA; Wang HM Dis Markers; 2015; 2015():239479. PubMed ID: 26640316 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor-1α/B-cell lymphoma 2 signaling impacts radiosensitivity of H1299 non-small cell lung cancer cells in a normoxic environment. Wang G; Xiao L; Wang F; Yang J; Yang L; Zhao Y; Jin W Radiat Environ Biophys; 2019 Aug; 58(3):439-448. PubMed ID: 31203382 [TBL] [Abstract][Full Text] [Related]
14. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia]. Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro. Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H Tumori; 2015; 101(5):578-84. PubMed ID: 26350185 [TBL] [Abstract][Full Text] [Related]
16. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. Jacoby JJ; Erez B; Korshunova MV; Williams RR; Furutani K; Takahashi O; Kirkpatrick L; Lippman SM; Powis G; O'Reilly MS; Herbst RS J Thorac Oncol; 2010 Jul; 5(7):940-9. PubMed ID: 20512076 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292 [TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Staab A; Fleischer M; Loeffler J; Said HM; Katzer A; Plathow C; Einsele H; Flentje M; Vordermark D Strahlenther Onkol; 2011 Apr; 187(4):252-9. PubMed ID: 21437769 [TBL] [Abstract][Full Text] [Related]
19. [Effects of hypoxia inducible factor-1α on P311 and its influence on the migration of murine epidermal stem cells]. Xu ZD; Li HS; Wang S; He WF; Wu J; Luo GX Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):287-294. PubMed ID: 28651420 [No Abstract] [Full Text] [Related]
20. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Palayoor ST; Tofilon PJ; Coleman CN Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]